13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001475373
申报总市值
US$4.6亿
US$4.6亿
38 檔
20.3%
根据最新整理的 13F 季度数据集，Sector Gamma As 于 Q2 2025 结束时的管理资产规模为 US$4.6亿。该机构在本季度申报了 38 档美股持仓，呈现出该时期的主要投资地图。
Sector Gamma As 在 Q2 2025 进行了结构性的板块轮动与仓位换股。在开立 6 个全新仓位及加仓 12 档持股的同时，亦同步清仓 1 档并减仓 17 档标的。
在资产配置集中度方面，Sector Gamma As 的前 5 大核心持股（包含 PFE, MDT, BMY 等）合计占整体申报市值的 20.3%，反映机构在主要关键仓位上的权重分布。
本季最大新建仓标的
MRK
市值: US$1599.0万
本季最大获利了结 / 清仓标的
JNJ
前期市值: US$1625.2万
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PFE | Pfizer Inc | 股票-医疗保健 | 7.29% | -1.99% | -0.54% | |
| 2 | MDT | Medtronic plc | 股票-医疗保健 | 6.38% | +0.24% | +9.27% | |
| 3 | BMY | Bristol-myers Squibb Co | 股票-医疗保健 | 6.14% | -2.78% | -6.67% | |
| 4 | BDX | Becton Dickinson And Co | 股票-医疗保健 | 5.52% | -0.01% | +19.51% | |
| 5 | MRK | Merck & Co. Inc. | 股票-医疗保健 | 5.23% | -1.34% | — | |
| 6 | GILD | Gilead Sciences Inc | 股票-医疗保健 | 4.60% | -1.75% | EXIT | |
| 7 | INCY | Incyte CORP | 股票-医疗保健 | 4.54% | -0.26% | +28.30% | |
| 8 | AMGN | Amgen Inc | 股票-医疗保健 | 4.02% | -1.86% | -25.42% | |
| 9 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 3.69% | +0.26% | — | |
| 10 | CVS | Cvs Health CORP | 股票-医疗保健 | 3.68% | +1.19% | -19.31% | |
| 11 | CAH | Cardinal Health Inc | 股票-医疗保健 | 3.62% | -0.64% | -25.00% | |
| 12 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 3.38% | +3.65% | NEW | |
| 13 | CNC | Centene CORP | 股票-医疗保健 | 2.70% | +1.00% | -14.12% | |
| 14 | BAX | Baxter International Inc | 股票-医疗保健 | 2.65% | — | +8.22% | |
| 15 | ZBH | Zimmer Biomet Holdings Inc | 股票-医疗保健 | 2.64% | -0.67% | -22.00% | |
| 16 | BRKR | Bruker CORP | 股票-医疗保健 | 2.64% | -0.18% | -7.55% | |
| 17 | ELV | Elevance Health Inc | 股票-医疗保健 | 2.39% | +0.69% | -34.75% | |
| 18 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 2.20% | +0.46% | -10.92% | |
| 19 | BIIB | Biogen Inc | 股票-医疗保健 | 2.08% | -1.36% | +171.68% | |
| 20 | HUM | Humana Inc | 股票-医疗保健 | 1.88% | -0.79% | EXIT | |
| 21 | QGEN | Qiagen N.V. | 股票-医疗保健 | 1.84% | — | -37.43% | |
| 22 | GEHC | GE Healthcare Technology | 股票-医疗保健 | 1.79% | +0.77% | +19.35% | |
| 23 | LH | Labcorp Holdings Inc | 股票-医疗保健 | 1.67% | +0.38% | — | |
| 24 | AVTR | Avantor Inc | 股票-医疗保健 | 1.64% | +0.66% | — | |
| 25 | PTCT | Ptc Therapeutics Inc | 股票-医疗保健 | 1.47% | +0.56% | — | |
| 26 | DXCM | Dexcom Inc | 股票-医疗保健 | 1.43% | +0.66% | — | |
| 27 | BIO | Bio-rad Laboratories-a | 股票-医疗保健 | 1.41% | +0.56% | +28.92% | |
| 28 | ELAN | Elanco Animal Health Inc | 股票-医疗保健 | 1.36% | — | -38.78% | |
| 29 | LNTH | Lantheus Holdings Inc | 股票-医疗保健 | 1.35% | -1.67% | EXIT | |
| 30 | BNTX | Biontech Se-adr | 股票-其他 | 1.30% | — | +24.90% | |
| 31 | TNDM | Tandem Diabetes Care Inc | 股票-其他 | 1.28% | -0.34% | +16.62% | |
| 32 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 1.07% | +0.05% | -65.85% | |
| 33 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 1.00% | — | — | |
| 34 | TGTX | Tg Therapeutics Inc | 股票-医疗保健 | 0.96% | — | +49.09% | |
| 35 | ASND | Ascendis Pharma A/S | 股票-其他 | 0.96% | -1.15% | EXIT | |
| 36 | SOLV | Solventum CORP | 股票-医疗保健 | 0.94% | — | +26.67% | |
| 37 | THC | Tenet Healthcare CORP | 股票-医疗保健 | 0.72% | — | -70.93% | |
| 38 | ACLXGBX | Arcellx Inc | 股票-其他 | 0.54% | — | -28.57% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | MRK | Merck & Co. Inc. | +5.2% | NEW | 新建仓 |
| 2 | TMO | Thermo Fisher Scientific Inc | +3.4% | NEW | 新建仓 |
| 3 | LH | Labcorp Holdings Inc | +1.7% | NEW | 新建仓 |
| 4 | AVTR | Avantor Inc | +1.6% | NEW | 新建仓 |
| 5 | INCY | Incyte CORP | +1.5% | +28.30% | 加仓 |
| 6 | DXCM | Dexcom Inc | +1.4% | NEW | 新建仓 |
| 7 | BIIB | Biogen Inc | +1.3% | +171.68% | 加仓 |
| 8 | HCA | Hca Healthcare Inc | +1% | NEW | 新建仓 |
| 9 | IONS | Ionis Pharmaceuticals Inc | +0.9% | — | 不变 |
| 10 | LNTH | Lantheus Holdings Inc | +0.6% | +101.20% | 加仓 |
| 11 | MDT | Medtronic plc | +0.5% | +9.27% | 加仓 |
| 12 | BNTX | Biontech Se-adr | +0.4% | +24.90% | 加仓 |
| 13 | BIO | Bio-rad Laboratories-a | +0.3% | +28.92% | 加仓 |
| 14 | TGTX | Tg Therapeutics Inc | +0.3% | +49.09% | 加仓 |
| 15 | SOLV | Solventum CORP | +0.2% | +26.67% | 加仓 |
| 16 | GEHC | GE Healthcare Technology | +0.2% | +19.35% | 加仓 |
| 17 | TNDM | Tandem Diabetes Care Inc | +0.2% | +16.62% | 加仓 |
| 18 | ASND | Ascendis Pharma A/S | +0.1% | — | 不变 |
| 19 | PTCT | Ptc Therapeutics Inc | 0% | — | 不变 |
| 20 | BAX | Baxter International Inc | -0.1% | +8.22% | 加仓 |
| 21 | BRKR | Bruker CORP | -0.2% | -7.55% | 减仓 |
| 22 | ACLXGBX | Arcellx Inc | -0.2% | -28.57% | 减仓 |
| 23 | PFE | Pfizer Inc | -0.2% | -0.54% | 减仓 |
| 24 | HUM | Humana Inc | -0.2% | -6.00% | 减仓 |
| 25 | ELAN | Elanco Animal Health Inc | -0.2% | -38.78% | 减仓 |
| 26 | CAH | Cardinal Health Inc | -0.3% | -25.00% | 减仓 |
| 27 | GILD | Gilead Sciences Inc | -0.4% | -9.29% | 减仓 |
| 28 | BDX | Becton Dickinson And Co | -0.5% | +19.51% | 加仓 |
| 29 | QGEN | Qiagen N.V. | -0.6% | -37.43% | 减仓 |
| 30 | CVS | Cvs Health CORP | -0.7% | -19.31% | 减仓 |
| 31 | CNC | Centene CORP | -0.7% | -14.12% | 减仓 |
| 32 | BMRN | Biomarin Pharmaceutical Inc | -0.9% | -10.92% | 减仓 |
| 33 | THC | Tenet Healthcare CORP | -1.1% | -70.93% | 减仓 |
| 34 | ZBH | Zimmer Biomet Holdings Inc | -1.5% | -22.00% | 减仓 |
| 35 | ELV | Elevance Health Inc | -1.6% | -34.75% | 减仓 |
| 36 | EW | Edwards Lifesciences CORP | -1.8% | -65.85% | 减仓 |
| 37 | AMGN | Amgen Inc | -1.9% | -25.42% | 减仓 |
| 38 | BMY | Bristol-myers Squibb Co | -2.4% | -6.67% | 减仓 |
| 39 | JNJ | Johnson & Johnson | -5.2% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Sector Gamma As 在 Q2 2025 季度的美股持仓总市值约为 US$4.6亿，共申报了 38 个公开持股仓位。
在 Q2 2025 季度，Sector Gamma As 按市值排列的前三大核心持股分别为：PFE (7.3%)、MDT (6.4%)、BMY (6.1%)。其中最大持股仓位 PFE 占据整体投资组合约 7.3% 的权重。
在 Q2 2025 季度中，Sector Gamma As 共进行了 36 项持仓异动，包含新建仓 6 个仓位、加仓 12 个仓位、减仓 17 个仓位以及清仓 1 个仓位。 其中最大新建仓标的为 MRK。 本季清仓仓位包含 JNJ。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。